Real-Time TMA* Technology for Fast, Sensitive, Reliable Culture-Free Microbial Detection
Imagine a system that can easily screen for Mycoplasma at various points in your process in just a few hours – giving you results comparable to those obtained with compendial testing. By screening at multiple points in your process, you can:
Strengthen your process risk mitigation plan
Keep your process moving forward with confidence that your product is Mycoplasma free
Robust and reliable Mycoplasma detection in 4 hours
Complete sample and assay protection from contamination.
Designed to meet the European Pharmacopeia 2.6.7 guidelines
A molecular assay anyone can run
Easy, closed, three step sample preparation
Semi-automated workflow with minimal hands-on time
Fast implementation with full support and validation services
Installation and training included with instrument purchase
Application development and validation services available
Mycoplasma testing expertise from MicroSafe Biosafety Solutions Laboratory, Europe
* Real-Time Transcription-Mediated Amplification (TMA) is a technology of Gen-Probe Incorporated.
Sign Up for a Lunch and Learn Sign Up for an On-site Lunch and Learn and find out how you can strengthen your Mycoplasma detection risk management in your drug process. >> Click Here
